PurposeTo evaluate diagnostic performance of four diagnostic methods for rapid determination of methicillin resistance in S. aureus positive blood cultures (BCs).MethodsClinical and spiked BCs were subjected to the evaluation of the following methods and protocols: a. Eazyplex (R) MRSA Plus loop-mediated isothermal amplification (LAMP) assay directly from BC fluid; b. MALDI-TOF MS subtyping on BC pellet extracted with Rapid Sepsityper (R) protocol and on 4-h short-term subculture; c. Clearview (TM) Culture Colony PBP2a SA immunochromatography assay on BC pellet and on 4-h short-term subculture; d. EUCAST RAST cefoxitin screen test performed directly from BC and including reading times at 4-h, 6-h and 16-20-h.ResultsEazyplex (R) MRSA plus exhibited the best performance, showing 100% sensitivity, specificity, positive predictive value, and negative predictive value, followed by PBP2a SA Culture Colony Clearview assay and EUCAST RAST cefoxitin screen. MALDI-TOF MS subtyping showed the lowest diagnostic accuracy (59.8 and 65.7% directly from BC and from 4-h subculture, respectively). In detail, sensitivity and specificity ranged from 24.3% to 20.4% and from 88.9% to 98.3% for protocols performed from BC pellet and 4-h subculture, respectively.ConclusionsThe Eazyplex (R) MRSA Plus and the immunochromatographic Clearview (TM) PBP2a SA Culture Colony methods can provide reliable results within 1 h from the start of positive BC processing. MALDI TOF MS subtyping showed unacceptable specificity by performing analysis from BC pellets, while its sensitivity depends on the prevalence of PSM-positive MRSA strains. The EUCAST RAST, based on disc diffusion, showed excellent performance with a time-to-result of at least 4 h.

Diagnostic methods and protocols for rapid determination of methicillin resistance in Staphylococcus aureus bloodstream infections: a comparative analysis

Matteo Boattini;Luisa Guarrasi;Sara Comini;Guido Ricciardelli;Roberto Casale;Rossana Cavallo;Cristina Costa;Gabriele Bianco
2025-01-01

Abstract

PurposeTo evaluate diagnostic performance of four diagnostic methods for rapid determination of methicillin resistance in S. aureus positive blood cultures (BCs).MethodsClinical and spiked BCs were subjected to the evaluation of the following methods and protocols: a. Eazyplex (R) MRSA Plus loop-mediated isothermal amplification (LAMP) assay directly from BC fluid; b. MALDI-TOF MS subtyping on BC pellet extracted with Rapid Sepsityper (R) protocol and on 4-h short-term subculture; c. Clearview (TM) Culture Colony PBP2a SA immunochromatography assay on BC pellet and on 4-h short-term subculture; d. EUCAST RAST cefoxitin screen test performed directly from BC and including reading times at 4-h, 6-h and 16-20-h.ResultsEazyplex (R) MRSA plus exhibited the best performance, showing 100% sensitivity, specificity, positive predictive value, and negative predictive value, followed by PBP2a SA Culture Colony Clearview assay and EUCAST RAST cefoxitin screen. MALDI-TOF MS subtyping showed the lowest diagnostic accuracy (59.8 and 65.7% directly from BC and from 4-h subculture, respectively). In detail, sensitivity and specificity ranged from 24.3% to 20.4% and from 88.9% to 98.3% for protocols performed from BC pellet and 4-h subculture, respectively.ConclusionsThe Eazyplex (R) MRSA Plus and the immunochromatographic Clearview (TM) PBP2a SA Culture Colony methods can provide reliable results within 1 h from the start of positive BC processing. MALDI TOF MS subtyping showed unacceptable specificity by performing analysis from BC pellets, while its sensitivity depends on the prevalence of PSM-positive MRSA strains. The EUCAST RAST, based on disc diffusion, showed excellent performance with a time-to-result of at least 4 h.
2025
1
11
S. aureus; Clearview™ PBP2a SA Culture Colony test; EUCAST RAST; Eazyplex® MRSA plus; Immunochromatography; MALDI-TOF MS subtyping; MRSA
Matteo Boattini; Luisa Guarrasi; Sara Comini; Guido Ricciardelli; Roberto Casale; Rossana Cavallo; Cristina Costa; Gabriele Bianco
File in questo prodotto:
File Dimensione Formato  
s10096-025-05039-2.pdf

Accesso aperto

Dimensione 968.57 kB
Formato Adobe PDF
968.57 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/2054830
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 5
social impact